SUSQUEHANNA INTERNATIONAL GROUP, LLP - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$130,172
-22.5%
166,888
-8.1%
0.00%
Q2 2023$167,980
+309.1%
181,600
+545.7%
0.00%
Q4 2022$41,064
-86.0%
28,126
-83.7%
0.00%
Q2 2022$293,000
-27.7%
172,312
-12.4%
0.00%
Q1 2022$405,000
-72.2%
196,807
-49.3%
0.00%
Q4 2021$1,456,000
-33.2%
388,376
-7.9%
0.00%
Q3 2021$2,181,000
+123.0%
421,914
+83.8%
0.00%
Q2 2021$978,000
-39.4%
229,610
-24.4%
0.00%
Q1 2021$1,613,000
-63.5%
303,744
-63.0%
0.00%
Q4 2020$4,422,000
+102.3%
821,002
+199.7%
0.00%
Q3 2020$2,186,000
-50.9%
273,900
-38.5%
0.00%
-100.0%
Q2 2020$4,455,000
+33.1%
445,100
+80.4%
0.00%
Q3 2018$3,346,000
+157.6%
246,763
+125.4%
0.00%
Q2 2018$1,299,000
-40.1%
109,500
-43.3%
0.00%
Q1 2018$2,168,000
+715.0%
193,105
+385.2%
0.00%
Q4 2017$266,000
+212.9%
39,800
+282.7%
0.00%
Q3 2017$85,000
+30.8%
10,400
-34.8%
0.00%
Q4 2016$65,000
-50.4%
15,941
+47.0%
0.00%
Q4 2015$131,00010,8440.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 6,287,101$4,903,9392.63%
Syncona Portfolio Ltd 1,377,294$1,074,2891.60%
MPM BioImpact LLC 5,095,912$3,974,8111.06%
NEA Management Company, LLC 17,079,778$13,322,2271.03%
TANG CAPITAL MANAGEMENT LLC 5,166,954$4,030,2240.57%
PFM Health Sciences, LP 10,423,135$8,130,0450.38%
Matrix Capital Management Company, LP 38,974,185$30,399,8640.36%
Long Focus Capital Management, LLC 10,963,158$8,551,2630.31%
Acuitas Investments, LLC 479,764$374,2160.22%
Endurant Capital Management LP 311,944$243,3160.22%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders